Fuad El-Hibri Wire

The El-Hibri Foundation is a nonprofit organization with the goal of fostering dialogue between various religions and encouraging nonviolent solutions to global challenges affecting humankind.  The Foundation has a new website at www.elhibrifoundation.org.

The Foundation, lead by Chairman of the Board of Trustees Fuad El-HIbri, is divided into four different initiatives: The Peace Education Initiative, The Interfaith Dialogue Initiative, The Humanitarian Aid Initiative, and The Social Justice Initiative.

Fuad El-Hibri awards the 2009 Peace Education award

The Peace Education Initiative focuses on conflict resolution, embracing cultural diversity, and supporting cross-cultural approaches to peace-building.  The Interfaith Dialogue Initiative focuses on supporting understanding between the three Abrahamic faiths: Islam, Judaism and Christianity.  The Humanitarian Aid Initiative provides grants to organizations that aim at delivering education and medical care to the disadvantaged.  The last of the four initiatives is the Social Justice Initiative.  The Social Justice Initiative addresses issues of equality, justice and human rights, especially for women and children.

The El-Hibri Foundation promotes these four initiatives through the provision of grants.  Since its creation in 2001, the Foundation has given away 36 grants totaling over 8.2 million dollars.

For more information on the El-Hibri Foundation visit their website:  www.elhibrifoundation.org

Emergent BioSolutions Inc., (EBS)

Q2 2009 Earnings Call

August 6, 2009 5:00 pm ET

Executives

Robert G. Burrows – Vice President, Investor Relations

Fuad El-Hibri – Chairman of the Board, Chief Executive Officer

R. Don Elsey – Chief Financial Officer

Daniel J. Abdun-Nabi – President, Chief Operating Officer

W. James Jackson, Ph.D. – Senior Vice President and Chief Scientific Officer

Analysts

Eric Schmidt – Cowen & Company

David Moskowitz – Caris & Company

Mona Ashiya – J.P. Morgan

Sean Long – Kennedy Capital Management

Presentation

Operator

Welcome to the Emergent BioSolutions Incorporated second quarter 2009 financial results conference call. (Operator Instructions) I would now like to turn the call over to Mr. Robert Burrows.

Robert Burrows

Good afternoon ladies and gentlemen. My name is Robert Burrows, Vice President of Investor Relations for Emergent. Thank you for joining us today as we discuss Emergent BioSolutions financial results for the second quarter and first six months of 2009. As is customary, our call today is open to all participants. In addition, the call is being recorded and is copyrighted by Emergent BioSolutions.

Joining me on the call this afternoon will be Fuad El-Hibri, Chairman and Chief Executive Officer, and Don Elsey, Chief Financial Officer. Additional members of our senior management team will be present on the call for purposes of the Q&A session.

Before we begin, however, I am compelled to remind everyone that during the all management may make projections and other forward-looking statements regarding future events and the company’s prospects or future performance. These forward-looking statements reflect Emergent’s current perspective on existing trends and information. Any such forward-looking statements are not guarantees of future performance and involve substantial risks and uncertainties. Actual results may differ materially from those projected in any forward-looking statements.

Good afternoon everyone. As Fuad mentioned following the close of … timing and the potential opportunity? Fuad El-Hibri Indeed, AIG remains a … or another contract for BioThrax. Fuad El-Hibri Fuad El-Hibri and Emergent BioSolutions Inc. Earnings Call Transcript

• Emergent BioSolutions Inc., Q1 2009 Earnings Call Transcript
• Emergent BioSolutions Inc. Q4 2008 Earnings Call Transcript 06 Mar, 2009

… in continued profitability. Finally, as Fuad mentioned, we continue to pursue … upfront versus development versus procurement? Fuad El-Hibri Well, let me first … Have you gone to that? Fuad El-Hibri For competitive reasons, I …

• Emergent BioSolutions Inc. Q3 2008 Earnings Call Transcript 21 Nov, 2008

… , and our recombinant trivalent botulinum vaccine. As Fuad mentioned these development contract revenues carry with … a protest. Cory Kasimov – JPMorgan Right. Okay. Fuad El-Hibri (inaudible). Cory Kasimov – JPMorgan …

• Emergent BioSolutions Inc. Q2 2008 Earnings Call Transcript 07 Aug, 2008

… Robert Burrows – VP, Corporate Communications Fuad El-Hibri – Chairman and CEO Don … follows Following my brief introduction, Fuad will provide comments on corporate … Company And I take from Fuad’s comments that you’re …

• Emergent BioSolutions Inc. Q1 2008 Earnings Call Transcript 07 May, 2008

… Robert Burrows – VP, Corporate Communications Fuad El-Hibri – Chairman and CEO Don … the call this morning is Fuad El-Hibri, our Chairman and Chief … sales, not in the quarter-over-quarter. Fuad El-Hibri Yes, that’s absolutely …

• Emergent Biosolutions Inc. Q4 2007 Earnings Call Transcript 07 Mar, 2008

… third generation anthrax vaccine, please. Fuad El-Hibri Thank you Richard, I … military for [executive] immunization program. Fuad El-Hibri I guess the best … monopolizing on the time here. Fuad El-Hibri You’re asking some …

• Emergent Biosolutions Q3 2007 Earnings Call Transcript 02 Nov, 2007

… straightforward. Following my brief introduction, Fuad will briefly discuss third quarter … to the discounted price that Fuad indicated earlier. This discounted price … is this a new customer? Fuad El-Hibri What I can disclose …